13.04
price down icon0.91%   -0.12
pre-market  시장 영업 전:  12.90   -0.14   -1.07%
loading
전일 마감가:
$13.16
열려 있는:
$13.04
하루 거래량:
1.27M
Relative Volume:
1.48
시가총액:
$1.19B
수익:
-
순이익/손실:
$-249.31M
주가수익비율:
-3.9396
EPS:
-3.31
순현금흐름:
$-209.70M
1주 성능:
-16.78%
1개월 성능:
-30.71%
6개월 성능:
-42.88%
1년 성능:
-40.75%
1일 변동 폭
Value
$12.62
$13.23
1주일 범위
Value
$12.62
$15.95
52주 변동 폭
Value
$12.62
$32.52

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
명칭
Rocket Pharmaceuticals Inc
Name
전화
646-440-9100
Name
주소
350 FIFTH AVENUE, NEW YORK, NY
Name
직원
268
Name
트위터
@rocketpharma
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
RCKT's Discussions on Twitter

RCKT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
RCKT 13.04 1.19B 0 -249.31M -209.70M -3.31
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-10-24 개시 Cantor Fitzgerald Overweight
2023-02-01 개시 Morgan Stanley Overweight
2022-11-08 개시 Canaccord Genuity Buy
2022-11-01 개시 BTIG Research Buy
2022-07-08 개시 Raymond James Outperform
2021-10-20 재개 Cowen Outperform
2021-03-02 개시 Stifel Buy
2021-02-18 개시 Needham Buy
2020-12-16 개시 UBS Buy
2020-12-08 다운그레이드 Oppenheimer Outperform → Perform
2020-07-02 개시 JP Morgan Overweight
2020-06-25 재개 BofA/Merrill Buy
2020-06-01 재개 Oppenheimer Outperform
2019-11-06 개시 Chardan Capital Markets Buy
2019-09-26 개시 Piper Jaffray Overweight
2019-04-23 개시 Robert W. Baird Outperform
2019-03-15 개시 BofA/Merrill Buy
2019-02-05 개시 Oppenheimer Outperform
2018-09-13 개시 Ladenburg Thalmann Buy
2018-07-10 개시 William Blair Outperform
모두보기

Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스

pulisher
02:57 AM

Needham & Company LLC Reiterates Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

02:57 AM
pulisher
02:57 AM

Cantor Fitzgerald Reaffirms “Overweight” Rating for Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

02:57 AM
pulisher
02:57 AM

Rocket Pharmaceuticals (NASDAQ:RCKT) Earns “Buy” Rating from Canaccord Genuity Group - Defense World

02:57 AM
pulisher
Nov 20, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Chardan Capital - Defense World

Nov 20, 2024
pulisher
Nov 19, 2024

Rocket Pharmaceuticals Advances Genetic Therapies Pipeline - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst - AOL

Nov 19, 2024
pulisher
Nov 19, 2024

Leerink Partners Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Cantor Fitzgerald Reiterates Overweight Rating for Rocket Pharmaceuticals (NASDAQ:RCKT) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Rocket Pharmaceuticals' (RCKT) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Rocket Pharmaceuticals shares hold strong with Buy rating By Investing.com - Investing.com UK

Nov 19, 2024
pulisher
Nov 19, 2024

First Turn Management LLC Purchases 60,317 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Rocket Pharma reports promising Phase 1 results for Danon disease therapy - Investing.com Australia

Nov 19, 2024
pulisher
Nov 18, 2024

Rocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment Slides - Asianet Newsable

Nov 18, 2024
pulisher
Nov 18, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week LowHere's What Happened - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Rocket Pharma's Danon Disease Treatment Shows 5-Year Success in Phase 1 Trial | RCKT Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Rocket Pharmaceuticals is Now Oversold (RCKT) - Nasdaq

Nov 15, 2024
pulisher
Nov 14, 2024

When (RCKT) Moves Investors should Listen - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Chardan Capital Has Strong Estimate for RCKT FY2024 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

RCKT stock touches 52-week low at $15.96 amid market challenges - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces pivotal year - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

Rocket Pharma to Present Groundbreaking Danon Disease Gene Therapy Data at AHA 2024 | RCKT Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline In Focus - Barchart

Nov 11, 2024
pulisher
Nov 11, 2024

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline in Focus - Yahoo Finance

Nov 11, 2024
pulisher
Nov 10, 2024

Privium Fund Management B.V. Has $5.45 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $51.75 - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition in Rocke - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference - BioSpace

Nov 08, 2024
pulisher
Nov 08, 2024

Rocket Pharmaceuticals' (RCKT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Rocket Pharmaceuticals: Q3 Earnings Snapshot - Houston Chronicle

Nov 08, 2024
pulisher
Nov 07, 2024

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Investors Appear Satisfied With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Prospects As Shares Rocket 41% - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance

Nov 07, 2024
pulisher
Nov 05, 2024

Harbor Capital Advisors Inc. Has $3.11 Million Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

Rocket Pharmaceuticals executive sells $51,205 in common stock - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Rocket Pharmaceuticals executive sells $51,205 in common stock By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 03, 2024

Long Term Trading Analysis for (RCKT) - Stock Traders Daily

Nov 03, 2024
pulisher
Oct 24, 2024

(RCKT) Trading Report - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire

Oct 22, 2024
pulisher
Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Oct 22, 2024
pulisher
Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - India Shorts

Oct 22, 2024
pulisher
Oct 21, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3%Here's What Happened - MarketBeat

Oct 21, 2024
pulisher
Oct 18, 2024

Fanconi Anemia Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Foresee Pharma, Rocket Pharma, John Diaz, Novartis, Sierra Oncology - The Globe and Mail

Oct 18, 2024
pulisher
Oct 17, 2024

Scotiabank Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Sector Outperform Recommendation - MSN

Oct 17, 2024
pulisher
Oct 16, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpWhat's Next? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Investors in cash trouble should check out Rocket Pharmaceuticals Inc (RCKT) - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Scotiabank - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

The Attractiveness of Investing In Rocket Pharmaceuticals Inc (RCKT) is Growing - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Rocket Pharmaceuticals Inc (RCKT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Recent Insider Activity Could Benefit Pacific Biosciences of California Inc (PACB) - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Verisk Analytics Inc [VRSK] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Rocket Pharmaceuticals Inc (RCKT)’s stock chart: A technical perspective - US Post News

Oct 15, 2024

Rocket Pharmaceuticals Inc (RCKT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
자본화:     |  볼륨(24시간):